1
rich
Libsyn
https://www.libsyn.com
90
600
CAR T-cell therapy with Dr. Mazyar Shadman
Dr. Mazyar Shadman is a blood cancer specialist at Fred Hutch Cancer Center who focuses on lymphoid malignancies. In a conversation with Bonnie Rochman, they explore the advancements in CAR T-cell therapy, particularly for large B-cell lymphoma, highlighting its impact on patient outcomes and survival rates.  Takeaways  CAR T therapy is a significant advancement in cancer treatment. The future of cancer treatment may heavily rely on CAR T advancements.  CAR T therapy represents a shift in cancer care paradigms. It is particularly effective for large B-cell lymphoma. Patients with relapsed disease historically had limited survival chances. CAR T therapy has improved outcomes for high-risk patients. 30 to 40% of patients are now being cured with CAR T therapy. The treatment offers better quality of life compared to standard care. Ongoing research is crucial for further advancements in CAR T. Patient selection is key for the success of CAR T therapy.
From Bench to Bedside and Beyond
https://sites.libsyn.com/591875
<iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/39169815/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe>
https://assets.libsyn.com/secure/content/195828875